Bionpharma
BionPharma: Developing and commercializing affordable, quality generic drugs through effective partnerships.
Founded
2014BionPharma: Developing and commercializing affordable, quality generic drugs through effective partnerships.
BionPharma, founded with a mission to develop and commercialize affordable, quality generic drugs, focuses on building strong and effective partnerships within the pharmaceutical industry. The company aims to empower its employees to engage with customers and partners, ensuring the execution of its business goals. BionPharma's product line includes a range of generic medications designed to provide cost-effective alternatives to brand-name drugs, targeting a broad market of healthcare providers and consumers seeking affordable medication options.
Notable figures affiliated with BionPharma include industry veterans who bring extensive experience in pharmaceutical development and commercialization. The company has achieved significant milestones in expanding its product portfolio and establishing key partnerships that enhance its market presence. BionPharma's impact is evident in its contribution to making essential medications more accessible and affordable, thereby improving healthcare outcomes for a wide range of patients.
Companies similar to Bionpharma include Solaris Pharma, Leading Pharma, Pyros Pharmaceuticals and Meitheal Pharmaceuticals.
Bionpharma was founded in 2014.
Bionpharma's headquarters is located in Princeton, NJ, US.
Bionpharma's most recent funding round was for $6.5M (USD) in December 2015.
As of Dec 14, 2015, Bionpharma has disclosed funding of $58.2M (USD). Undisclosed round amounts are excluded.
Bionpharma has 36 employees as of Feb 5, 2024.
Meitheal Pharmaceuticals
meithealpharma.com
